41 related articles for article (PubMed ID: 11737473)
1. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer.
Halperin R; Zehavi S; Langer R; Hadas E; Bukovsky I; Schneider D
Int J Gynecol Cancer; 2001; 11(5):403-8. PubMed ID: 11737473
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of the relationship between experience of death of a relative, illness perception, and psychological outcome among BRCA carriers.
Samama D; Hasson-Ohayon I; Perry S; Morag O; Goldzweig G
Psychol Health Med; 2014; 19(6):698-704. PubMed ID: 24279344
[TBL] [Abstract][Full Text] [Related]
3. Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer.
Trainer AH; Meiser B; Watts K; Mitchell G; Tucker K; Friedlander M
Int J Gynecol Cancer; 2010 Jul; 20(5):704-16. PubMed ID: 20973257
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study.
Chen M; Wen Z; Qi Z; Gao M
Front Oncol; 2021; 11():651969. PubMed ID: 34490079
[TBL] [Abstract][Full Text] [Related]
5. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.
Fortner RT; Rice MS; Knutsen SF; Orlich MJ; Visvanathan K; Patel AV; Gaudet MM; Tjønneland A; Kvaskoff M; Kaaks R; Trichopolou A; Pala V; Onland-Moret NC; Gram IT; Amiano P; Idahl A; Allen NE; Weiderpass E; Poynter JN; Robien K; Giles GG; Milne RL; Setiawan VW; Merritt MA; van den Brandt PA; Zeleniuch-Jacquotte A; Arslan AA; O'Brien KM; Sandler DP; Wolk A; Håkansson N; Harris HR; Trabert B; Wentzensen N; Tworoger SS; Schouten LJ
Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):2010-2018. PubMed ID: 32732252
[TBL] [Abstract][Full Text] [Related]
7. Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC.
Katou S; Feist M; Raue W; Pratschke J; Rau B; Brandl A
Visc Med; 2018 Aug; 34(4):307-309. PubMed ID: 30345290
[TBL] [Abstract][Full Text] [Related]
8. Extraovarian Primary Peritoneal Carcinomatosis: A Case Report.
Nicolas G; Kfoury T; Fawaz H; Issa M
Am J Case Rep; 2017 Jun; 18():714-718. PubMed ID: 28649123
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.
Cobb LP; Gaillard S; Wang Y; Shih IeM; Secord AA
Gynecol Oncol Res Pract; 2015; 2():1. PubMed ID: 27231561
[TBL] [Abstract][Full Text] [Related]
10. When is it safe to omit surgery in primary peritoneal cancer with small volume disease?
Pounds R; Kehoe S
Curr Oncol Rep; 2015 Aug; 17(8):36. PubMed ID: 26045131
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and conditional disease-free survival among patients with ovarian cancer.
Kurta ML; Edwards RP; Moysich KB; McDonough K; Bertolet M; Weissfeld JL; Catov JM; Modugno F; Bunker CH; Ness RB; Diergaarde B
J Clin Oncol; 2014 Dec; 32(36):4102-12. PubMed ID: 25403208
[TBL] [Abstract][Full Text] [Related]
12. Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.
Lv H; Shi Y; Zhang L; Zhang D; Liu G; Yang Z; Li Y; Fei F; Zhang S
BMC Cancer; 2014 Aug; 14():576. PubMed ID: 25106448
[TBL] [Abstract][Full Text] [Related]
13. Tumorgrafts as in vivo surrogates for women with ovarian cancer.
Weroha SJ; Becker MA; Enderica-Gonzalez S; Harrington SC; Oberg AL; Maurer MJ; Perkins SE; AlHilli M; Butler KA; McKinstry S; Fink S; Jenkins RB; Hou X; Kalli KR; Goodman KM; Sarkaria JN; Karlan BY; Kumar A; Kaufmann SH; Hartmann LC; Haluska P
Clin Cancer Res; 2014 Mar; 20(5):1288-97. PubMed ID: 24398046
[TBL] [Abstract][Full Text] [Related]
14. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract][Full Text] [Related]
15. Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
Grant DJ; Moorman PG; Akushevich L; Palmieri RT; Bentley RC; Schildkraut JM
Cancer Causes Control; 2010 Jul; 21(7):991-8. PubMed ID: 20309725
[TBL] [Abstract][Full Text] [Related]
16. The invasive malignancy from peritoneal epithelial cell: a report of four cases and review of literature.
Hongjian X; Jiquan F; Gang P; Rubo C
Med Oncol; 2011 Jun; 28(2):597-600. PubMed ID: 20300975
[TBL] [Abstract][Full Text] [Related]
17. Serous adenocarcinoma of the retroperitoneum, as a type of multifocal müllerian carcinoma.
Iura A; Sasajima Y; Katsumata N; Kasamatsu T
Int J Clin Oncol; 2009 Jun; 14(3):254-7. PubMed ID: 19593619
[TBL] [Abstract][Full Text] [Related]
18. Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?
Goodman MT; Shvetsov YB
Int J Cancer; 2009 May; 124(9):2231-5. PubMed ID: 19127596
[TBL] [Abstract][Full Text] [Related]
19. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.
Goodman MT; Shvetsov YB
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):132-9. PubMed ID: 19124490
[TBL] [Abstract][Full Text] [Related]
20. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
Carlson JW; Miron A; Jarboe EA; Parast MM; Hirsch MS; Lee Y; Muto MG; Kindelberger D; Crum CP
J Clin Oncol; 2008 Sep; 26(25):4160-5. PubMed ID: 18757330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
